Change, LSM /C6SE (95% CI) −0.06/C60.02 ( −0.09, −0.02) −0.02/C60.02 ( −0.06, +0.02) −0.04 ( −0.07, 0.00); P=.031c Non-HDL cholesterol, mmol/Ld Baseline, mean /C6SD 3.33 /C60.92 3.13 /C61.05 Week 28, mean /C6SD 3.40 /C61.08 3.27 /C61.12 Change, LSM /C6SE (95% CI) +0.06 /C60.08 ( −0.10, +0.22) +0.08 /C60.08 ( −0.09, +0.24) −0.02 ( −0.17, +0.14); P=.845c Triglycerides, mmol/Ld,g Baseline, mean /C6SD 1.59 /C60.06 1.55 /C60.05 Week 28, mean /C6SD 1.74 /C60.07 1.68 /C60.06 Ratio, geometric LSM /C6SE (95% CI) +1.10 /C60.04 (+1.03, +1.18) +1.09 /C60.04 (+1.01, +1.17) +1.01 ( −0.94, +1.09); P=.699c Abbreviations: CI, confidence interval; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HbA1c, glycated haemoglobin; HDL, high-dens ity lipo- protein; IG, insulin glargine; LDL, low-density lipoprotein; LSM, least-squares mean; MMRM, mixed-effects model for repeated measures; PPG, post pran-